Results 341 to 350 of about 181,705 (382)

Kidney, the Cinderella Story of Transthyretin Amyloidosis. [PDF]

Kidney Int Rep
Leung N.
europepmc   +1 more source

MiRNA‐501‐3p and MiRNA‐502‐3p: A promising biomarker panel for Alzheimer's disease

Clinical and Translational Medicine, Volume 15, Issue 7, July 2025.
MiR‐501‐3p and miR‐502‐3p expression is elevated in AD CSF exosomes, AD serum exosomes, AD B‐lymphocytes and Aβ‐ and Tau‐treated cells. MiR‐501‐3p and miR‐502‐3p are correlated with amyloid plaque and NFT tangle density in specific brain regions. MiR‐501‐3p and miR‐502‐3p are highly expressed in neurons and astrocytes, suggesting that these cells are ...
Davin Devara, Bhupender Sharma, Gunjan Goyal, Daniela Rodarte, Aditi Kulkarni, Nathan Tinu, Ayana Pai, Subodh Kumar   +7 more
wiley   +1 more source

Treatment with vutrisiran in people with transthyretin amyloidosis with cardiomyopathy: a plain language summary. [PDF]

Future Cardiol
Fontana M, Gillmore JD, Witteles RM, Laryea B, Dworkin M, Payne A, Kochman F, Eraly S, Maurer MS.   +8 more
europepmc   +1 more source

Incidental Cardiac Uptake Leading to Early Diagnosis of Hereditary Transthyretin Amyloidosis. [PDF]

Circ Rep
Biyajima M, Tsuyuzaki J, Eizawa T, Sekijima Y.   +3 more
europepmc   +1 more source

Membranous nephropathy concurrent with renal amyloidosis: a six-patient report and literature review. [PDF]

Ren Fail
Li Z, Liu J, Zhu S, Zhang M, Xu F, Jiao C, Huang X, Cheng Z, Zuo K.   +8 more
europepmc   +1 more source

Prophylactic implantation of cardioverter-defibrillator in patients with advanced light-chain amyloidosis-A pilot study. [PDF]

J Arrhythm
Wei HQ, Wang J, Liang Y, Xia S, Li L, Zhong L.   +5 more
europepmc   +1 more source

Identification of fibrinogen Aα-chain as an amyloid precursor protein in a case of canine coronary artery amyloidosis. [PDF]

J Vet Diagn Invest
Iwaide S, Wachoski-Dark GL, Murakami T, Sedghi Masoud N, Itoh Y, Hisada M, Kimura K, Shibahara T, Haritani M, Caswell JL.   +9 more
europepmc   +1 more source